baber/WOPTO huggingface dataset:
Patent NZ-331136-A (NZ)
Title: Transmission of registration parameters using supervisory messages in radiocommunications
Inventor: KALLIN HARALD
IPC: H04B7/26
Filed: 1995-12-14
Abstract: n order to transmit registration parameters on a control channel the supervisory messages are grouped together for periodic transmission on the control channel.  A first registration parameter indicating the current time and a second registration parameter indicating a time for periodic registration relative to the current time are provided.  The second registration parameter is transmitted before and adjacent to the first registration parameter when the first parameter is included in a group of the supervisory messages to be transmitted on the control channel.  Only some of the groups of supervisory messages include the first registration parameter.
Patent NZ-331807-A (NZ)
Title: Side by side endless baggage conveyor with belt twist between runs
Inventor: MENSCH WILLIAM A
IPC: B65G15/60
Filed: 1998-09-09
Abstract: A baggage conveyor for use in such places as airports consists of two side-by-side belt runs 7, 9.  The two runs travel in opposite directions, at the same level and are formed by a single endless belt.  At each end 11, 15, 19, 23 of the belt runs, the belt is led over twist assemblies 38, 35 which twist the belt so that the same surface is uppermost on both belt runs.  Each twist assembly consists of two twist rolls 65, 67.  The rolls may be vertical as shown, or may be tapered or hourglass shaped horizontal rollers.
Patent NZ-334670-A (NZ)
Title: IC module, IC card, sealing resin and IC module fabricating method
Inventor: SHIMADA NAOKI
IPC: H01L23/31
Filed: 1998-07-16
Abstract: Described is an IC card (10) comprising a base card (20), and an IC module (11) placed in a recess (21) formed in the base card (20). The IC module (11) has a substrate (12), a terminal member (13) formed on one of the surfaces of the substrate (12), and an IC chip (14) attached to the other surface of the substrate (12). The terminal member (13) is connected to the IC chip (14) by wires (15), and the IC chip (14) and the wires (15) are covered with a sealing resin covering (16). The sealing resin covering (16) is formed of a sealing resin containing a resin component and a solid component. The ratio in weight of the resin component to the solid component in a near-surface layer of the sealing resin covering (16) is in the range of 90:10 to 100:0.
Patent NZ-501236-A (NZ)
Title: Intravaginal drug delivery devices for the administration of testosterone and testosterone precursors in a polymer matrix and surrounded by a sheath
Inventor: PASSMORE CLARE
IPC: A61P43/00
Filed: 1998-05-07
Abstract: An intravaginal shell or core drug delivery device suitable for administration to a female comprises testosterone or a testosterone precursor in a polymer matrix and surrounded by a sheath.  The device is capable of releasing the testosterone or testosterone precursor in a substantially zero order pattern on a daily basis for at least three weeks with the testosterone or testosterone precursor possessing physiochemical properties such that they may be delivered from the device at a daily rate that will alleviate or prevent symptoms associated with testosterone deficiency or, alternatively, induce supra therapeutic testosterone levels and the testosterone precursor being metabolisable, in vivo, to release testosterone.
Patent NZ-503302-A (NZ)
Title: Pharmaceutical compositions containing plasma protein noncovalently bonded to an active compound with low aqueous solubility and binding affinity to the plasma protein
Inventor: HEGEDUS LAJOS
IPC: A61K47/42
Filed: 1998-09-17
Abstract: A water-soluble organic solvent free product comprises: a) a therapeutically active compound having a aqueous solubility of <1.0-4 M/Lit and a substantial binding affinity to plasma proteins of component b); b) a plasma protein fraction in a controlled aggregation state; whereby the active compound and the protein fraction are bound to each other by way of a non-covalent bond and optionally containing: c)  pharmaceutically acceptable preferably parenterally acceptable formulation additives such as water, stabilizers and protein aggregation controllers. Also disclosed is a pharmaceutical formulation in solid or liquid form and a parenteral organic solvent free true aqueous solution thereof. The protein fraction can be a natural or recombinant immunoglobulin, interferon, glycoproteins or interleukin. The active compound can be a taxonoid, antibiotic, vitamin, analgesic, antiviral, anticonvulsant, antifungal agent, steroid hormone, immunosuppressant or antiarrhythmic agent.
Patent NZ-504569-A (NZ)
Title: Use of beta-amyloid peptide for inducing an immunogenic response and use in the treatment of alzheimer's disease
Inventor: SCHENK DALE B
IPC: A61K38/00
Filed: 1998-11-30
Abstract: Compositions and the use of the compositions are provided for the reatment of amyloidogenic diseases. The use of the compositions entails administering an agent that induces a beneficial immune response against an amyloid deposit in the patient. The treatment is particularly useful for prophylactic and therapeutic treatment of Alzheimer's disease. In this treatment, a suitable agent is Abeta peptide, a fragment thereof or an antibody thereto.
Patent NZ-507192-A (NZ)
Title: Circuit breaker panel with clip-on feature for street lights
Inventor: FISH LAWRENCE
IPC: H01H71/02
Filed: 2000-09-27
Abstract: A street light circuit breaker panel. The panel consists a back panel, which is attached to the street light by clips. Mounted on the back panel is a terminal block and circuit breaker. The arrangement is intended to prevent the street light pole from coming into electrical contact with the circuit breaker.
Patent NZ-508016-A (NZ)
Title: Spiro compounds for preventing and/or treating autoimmune diseases
Inventor: CHAKI HISAAKI
IPC: C07K5/078
Filed: 1999-04-28
Abstract: A spiro compound of formula (I) or a salt thereof wherein: A is -CH(Y-R1a)-, -CH(CH2-R1b)-, -C[=C(R1c)2]-, -C(R1e)2-, -C(H)(R1g)-or -N(R1h)-; R2 is a hydrogen atom, a formyl group, an alkanoyl group, an aralkylcarbonyl group, or an optionally substituted alkyl, alkenyl, cycloalkyl, aroyl, heterocyclic carbonyl, aryl, aralkyl, alkylsulohonyl, arylsulphonyl or heterocyclic group; R3 and R4 are independently a hydrogen atom, a halogen atom, a cyano group, an optionally protected carboxyl group or hydroxyl group or an optionally substituted alkyl, alkenyl, cycloalkyl, alkoxy, alkylthio, alkylsulphinyl, alkylsulphonyl, acyl, alkoxycarbonyl, aryl, amino, alkylamino, acylamino, carbamoyl or heterocyclic group, or together are an oxo group; R5 and R6 are independently a hydrogen atom, a halogen atom, a cyano group, an optionally protected carboxyl group or hydroxyl group or an optionally substituted alkyl, alkenyl, cycloalkyl, alkoxy, alkylthio, alkylsulphinyl, alkylsulphonyl, acyl, alkoxycarbonyl, aryl, amino, alkylamino, acylamino, carbamoyl or heterocyclic group, or together with the terminal carbon atom to which they are attached form an alkenyl group; n is 0, 1 or 2 and R1a, R1b, R1c, R1e, R1g and R1h are as defined in the specification. An agent thereof is useful for preventing and/or treating autoimmune diseases.
Patent NZ-508480-A (NZ)
Title: Structural frame elements and method for forming a modular building
IPC: E04C3/04
Filed: 2000-11-28
Abstract: A modular unit system for constructing modular structures comprising a plurality of generally different modular unit sets each having plurality of identical modular units, the modular units of at least one of the modular unit sets having a ladder like configuration (2,3).  The modular units have corresponding connecting surfaces and so that a modular structure can be constructed.
Patent NZ-510640-A (NZ)
Title: Apparatus and steam injection method for making a consolidated cellulosic product
Inventor: DODD WILLIAM R
IPC: B27N3/08
Filed: 1999-08-04
Abstract: A method of making a cellulosic composite article using a steam injection pressing operation.  The method involves the steps of: (a) combining a resin binder with cellulosic material to form a mixture; (b) forming a mat from the mixture of step (a); (c) consolidating the mat under steam, and pressure in a pressing apparatus including a pair of heated platens including a steam injection platen that includes a plurality of openings for the passage of steam therethrough; (d) providing a slotted steam distribution plate adjacent to the steam injection platen and in contact with the mixture, the slotted steam distribution plate having slots that intersect the openings in the slotted steam injection platen, the slots in the steam distribution plate providing a steam injection open area comprising at least 6% of a major adjacent surface of the composite article; (e) injecting steam through the openings in the slotted steam injection platen and through the slots in the steam distribution plate to achieve complete contact of the mixture with the steam to consolidate the mixture into a cellulosic article having structural integrity and to cure the resin binder; and (f) discharging the steam from a steam injection-side of the pressing apparatus.
Patent NZ-510941-A (NZ)
Title: Device and method for eliminating severe slugging in multiphase-stream flow lines, typically in form of venturi, to promote reorganisation of phases in stratified pattern
Inventor: DE ALMEIDA ALCINO RESENDE
IPC: E21B43/01
Filed: 1999-09-10
Abstract: The present disclosure relates to a device located near to the point of junction of a multiphase-stream underwater flow line with a stratified phase pattern, and an underwater riser, which introduces a pressure drop into the flow and causes a vigorous mixing effect, temporarily converting this flow into a non-stratified pattern of flow, such as an annular stream, thereby preventing the establishment of the phenomenon of severe slugging.
Patent NZ-514708-A (NZ)
Title: Novel cytokine zalpha11 ligand
Inventor: PRESNELL SCOTT R
IPC: A61K38/00
Filed: 2000-03-09
Abstract: Described are zalpha11 Ligand polynucleotide and polypeptide molecules; the zalpha11 Ligand is a cytokine. The polypeptides may be used within methods for stimulating the proliferation and/or development of hematopoietic cells in vitro and in vivo. Methods for producing the protein are also provided in addition to uses therefor and antibodies thereto.
Patent NZ-515483-A (NZ)
Title: Microbial protein expression system for secretion of a recombinant heterologous protein into periplasm of bacteria
Inventor: KORPELA TIMO
IPC: C12N15/70
Filed: 2000-05-03
Abstract: A  bacterial strain simultaneously expressing a fusion protein comprising: a  signal  peptide,  a  mature heterologous  protein  and  a subunit of a bacterial surface structure enabling production of  recombinant  heterologous proteins in the  periplasm  of bacteria in a soluble, biologically active form; and  a periplasmic chaperone specific for said subunit,  for secretion  of a recombinant heterologous protein in  to  the periplasm of bacteria.
Patent NZ-516405-A (NZ)
Title: Insecticidal liquid bait station
Inventor: MAJEROWSKI AMELIA H
IPC: A01M1/20
Filed: 2000-06-30
Abstract: An insect bait station (10) includes: a reservoir (40) for holding a liquid bait (42), the reservoir (40) having a mouth and a closure for sealing the mouth such that the liquid bait is contained in the reservoir; a piercer (160) for opening the closure of the reservoir (40) such that a liquid wicking device positioned in the mouth of the reservoir may transport the liquid bait (42) from the reservoir (40) and through the mouth of the reservoir; and an activation member (80) for moving the piercer (160) into contact with the closure of the reservoir to open the closure, wherein the insect bait station also comprises an insecticide.
Patent NZ-518106-A (NZ)
Title: Game machine controller codes set in accordance with game status
Inventor: TANAKA MAKOTO
IPC: A63F13/235
Filed: 2000-09-08
Abstract: The time required to communication between an entertainment apparatus (12) and a manual controller (200) having complex and sophisticated functions which is connected to the entertainment apparatus (12) is reduced. A type of control data to be outputted from a manual controller (200) when control units including direction keys are operated is defined (limited) according to an application program that is recorded in an optical disk (OD) and read by the entertainment apparatus (12). The manual controller (200) has a setting register for setting such a type of control data. After a type of control data is defined in the setting register of the manual controller (200) from the entertainment apparatus (12), a CPU of the manual controller (200) transmits only control data of the type set in the setting register for each frame of image. By thus limiting types of control data to be transmitted, the time required to communication between the entertainment apparatus (12) and the manual controller (200) is shortened.
Patent NZ-518449-A (NZ)
Title: Positive modulators of nicotinic receptor agonists
Inventor: GURLEY DAVID
IPC: A61P1/04
Filed: 2000-11-01
Abstract: A compound of Formula (I) is described, wherein R1 represents hydrogen, C1-C4 alkyl, C2-C4 alkenyl, C2-C4 alkynyl, or (CH2)nAr; W represents C(O), C(O)O, C(O)NR6, or a bond; R2 represents hydrogen, Ar, or (CH2)pCH[(CH2)qR7](CH2)tR8; or together R2 and R6 represent (CH2)jY(CH2)k; R3 and R5 independently represent hydrogen, halogen, or C1-C4 alkyl; X represents oxygen, or NH; R4 represents hydrogen, C1-C4 alkyl(CH2)uAr, R9CO, or R9SO2; R6 represents hydrogen, C1-C4 alkyl, aryl or heteroaryl, or together R2 and R6 represent (CH2)jY(CH2)k; R7 and R8 independently represent hydrogen, halogen, CN, -CCH, N3, CF3, NO2, Ar, OR10, NR10R11, C(O)OR10, OC(O)R10, C(O)NR10R11, NR10C(O)R11, SO2NR10R11, or NR10SO2R11; R9 represents C1-C4 alkyl, or Ar; Ar represents phenyl, naphthyl, or a 5- or 6-membered heterocyclic ring containing 0-3 nitrogens, 0-1 sulphurs and 0-1 oxygens; Ar is optionally substituted with one or more substituents independently selected from: hydrogen, halogen, C1-C4 alkyl, C2-C4 alkenyl, C2-C4 alkynyl, (CH2)naryl, CN, NO2, CF3, OR12, NR12R13 and COOR12; R10, R11, R12 and R13 independently represent hydrogen, C1-C4 alkyl, aryl, or heteroaryl; or together R10 and R11 and/or R12 and R13 independently represent (CH2)jY(CH2)k; Y represents oxygen, sulphur, NR14, or a bond; j is 2-4; k, m, n, p, q, t and u are independently 0-2; R14 represents hydrogen, C1-C4 alkyl, aryl or heteroaryl; or an enantiomer thereof, and pharmaceutically acceptable salts thereof, processes for preparing them, pharmaceutical compositions containing them and their use in therapy, especially for treatment of conditions associated with reductions in nicotinic transmission. The compounds of the invention enhance the efficacy of agonists at nicotinic receptors.
Patent NZ-519328-A (NZ)
Title: Orally administrable pharmaceutical product and method of fabrication therefor
Inventor: CANHAM LEIGH TREVOR
IPC: A61J7/04
Filed: 2000-11-20
Abstract: An orally administrable pharmaceutical product comprises an information carrier having a form and composition such that information is recorded by the carrier; wherein the information carrier comprises a resistant material that is resistant to the gastric environment. The information carrier can be a semiconductor or a fluorescent or photoluminescent material.
Patent NZ-519700-A (NZ)
Title: Method of gluing and apparatus therefor
Inventor: NASLI-BAKIR BENYAHIA
IPC: B29C65/52
Filed: 2000-12-15
Abstract: The disclosure relates to a method of manufacturing composite products. Thereby a number of elements to be assembled is provided and glue is applied to at least one surface of each element. The elements are assembled, and the assembled elements are subjected to pressure in a press. The invention is characterized in that amount of at least one component of the glue, applied at a specific point of glue application on an element, is controlled to be a function of the waiting time it takes before the point of glue application is subjected to the pressure in the press. It also relates to an apparatus for carrying out the method which is characterized by a control unit (15) which is programmable to run a control sequence for the glue applicator (10) and/or the element feeder (6; 16) to provide an optimal applied glue amount.
Patent NZ-523858-A (NZ)
Title: Method and apparatus for dispensing liquids in aerosolized form with minimum spillage
Inventor: MARTENS EDWARD J
IPC: B05B17/06
Filed: 2001-07-31
Abstract: A liquid (31) is held in a high viscosity solids suspension in a reservoir (30) and is separated from the suspension by a capillary element (32) which transfers the liquid to a vibrating orifice plate (14) from which the liquid is ejected in the form of aerosolised liquid droplets.
Patent NZ-524997-A (NZ)
Title: A sheet
Inventor: VLASSIS CONNIE
IPC: A47G9/04
Filed: 2001-08-29
Abstract: A sleeping sheet, for detachably coupling to a sleeping apparatus, including a top portion (8) a bottom portion (7) including an attachment means (10), wherein the top portion (8) is coupled to said bottom portion (7), wherein the attachment means (10) may be coupled to said sleeping apparatus in a detachable arrangement.
Patent NZ-527081-A (NZ)
Title: Aniline derivatives useful as phosphodiesterase 4 inhibitors
Inventor: HOPPER ALLEN
IPC: A61K31/4406
Filed: 2002-01-22
Abstract: Disclosed are compounds of formula I, wherein: R1 is optionally substituted alkyl, R2 is optionally substituted alkyl, cycloalkyl, cycloalkylalkyl, aryl, arylalkyl, heterocycle, or heterocyclicalkyl, R3 is optionally substituted alkyl, carbocycle-alkyl, arylalkyl, or heteroarylalkyl, R4 is optionally substituted aryl or heteroaryl, R5 is optionally substituted H, alkyl, alkylamino, carbocycle-alkyl, cycloalkyl, cycloalkylalkyl, aryl, arylalkyl, heterocycle, or heterocyclicalkyl, L is a single bond or a divalent radical, and R6 is H or is optionally substituted alkyl. The compounds are used in the manufacture of medicaments for the treatment of memory impairment due to neurodegenerative disease, or treatment of an allergic or inflammatory disease.
Patent NZ-528749-A (NZ)
Title: Implantable prosthetic or tissue expanding device
Inventor: HSU KEN Y
IPC: A61F2/12
Filed: 2002-03-20
Abstract: An intervertebral disc implant comprises a layer of keratin material which is adapted to be inserted between adjacent vertebral bodies and comprises a keratin hydrogel. The keratin hydrogel is preferably formed of keratin in which the cysteine amino acids are free of extrinsic chemical groups added by reduction of cysteine disulfide bonds. Also described is the use of sheets of keratin based material for making an annular repair device for repairing a spinal disc annulus.
Patent NZ-529174-A (NZ)
Title: Method and an unleaded low emission gasoline for fuelling an automotive engine with reduced emissions
Inventor: WOLF LESLIE R
IPC: F02B1/12
Filed: 2002-05-02
Abstract: Disclosed herein is an unleaded low emissions gasoline for use in an internal combustion engine having an octane (R+M)/2 less than 86.7 and a sulfur content less than 40 ppmw and optionally containing an oxygenate selected from the group consisting of ethanol, methyl tertiary butyl ether, ethyl tertiary butyl ether, and tertiary amyl ether, and having reduced emissions by comparison to a minimum 87 octane gasoline.
Patent NZ-529367-A (NZ)
Title: Adhesive strip as opening indicator and method of application.
Inventor: EGGERMONT PHILIPPE
IPC: B31B19/90
Filed: 2003-11-06
Abstract: Reclosable bag comprising two walls forming a mouth on which are fixed opening and closing means, an actuating slider for the said closing means, an opening indicator means, wherein the opening indicator means comprises a strip bonded to an external surface of the opening and closing means and of the actuating slider, the strip having a width substantially equal to the width of the external surface of the opening and closing means, and length substantially greater than that of the said opening and closing means so as to define at least one end capable of being gripped by a user.
Patent NZ-535515-A (NZ)
Title: Secondary metabolite congener distribution modulation
Inventor: LICARI PETER J
IPC: C12N15/52
Filed: 2003-02-25
Abstract: Disclosed is a method of increasing the ratio of epothilone congeners having a C-12 methyl to epothilone congeners having a C-12 hydrogen produced by a Myxococcus xanthus host cell, comprising the steps of cultivating said host cell in growth medium under conditions that lead to the production of epothilone, and modulating oxygen tension to about 50% of saturation, resulting in increasing the ratio of epothilone congeners having a C-12 methyl. Also disclosed is a method of modulating epothilone congener distribution production ration in a myxobacterial host cell, wherein said congeners differ in having either a 12,13-alkene or a 12,13-epoxide, comprising the steps of cultivating said host cell in growth medium under conditions that lead to the production of epothilones, and modulating oxygen tension during cultivation of said hosts cells, resulting in shifting production of species of said epothilone congeners.
Patent NZ-538719-A (NZ)
Title: Non-sequence complementary antiviral oligonucleotides
Inventor: VAILLANT ANDREW
IPC: A61K48/00
Filed: 2003-09-11
Abstract: Use of at least one oligonucleotide comprising at least one phosphorothioated linkage, wherein the oligonucleotide does not have an antiviral activity occurring by a sequence complementary mode of action, and wherein said oligonucleotide is at least 29 nucleotides in length, in the manufacture of a pharmacological formulation for the prophylaxis or treatment of a viral infection. Also disclosed is the use of said oligonucleotides for treating or preveting cancer caused by oncoviruses.
Patent NZ-544679-A (NZ)
Title: A method of coordinating and stabilizing the delivery of wind generated energy
Inventor: ENIS BEN M
IPC: F03D9/00
Filed: 2004-06-14
Abstract: A method of coordinating and stabilizing the delivery of wind generated power is disclosed. The method comprises the steps of: (a) using a wind farm that has a plurality of windmill stations, where the wind farm comprises a predetermined number of immediate use stations, energy storage stations, and hybrid stations, for providing wind generated power; (b) forecasting or obtaining a forecast of wind speed conditions at the wind farm for an upcoming period of time; (c) using the forecasts to predict the wind speed conditions and the resulting wind power availability levels for the upcoming period of time; (d) storing wind generated energy in the form of compressed air in the energy storage stations and/or the hybrid stations; (e) preparing an energy delivery schedule based on the predictions for wind speed and wind power availability levels for the upcoming period, utilizing energy derived from both immediate use and energy storage windmill stations, and as necessary, the hybrid stations; and (f) using the delivery schedule to set a reduced number of constant power output periods during the upcoming period of time, during which time energy delivery levels can remain substantially constant, despite fluctuations and oscillations in wind speed and wind power availability levels.
Patent NZ-546930-A (NZ)
Title: Insect behaviour modifying compounds
Inventor: DAVIDSON MELANIE MILLICENT
IPC: A01N43/40
Filed: 2004-11-12
Abstract: Disclosed are methods of controlling, surveying or regulating thrips populations comprising providing at least one thrips behaviour modifying compound of formula (I), wherein the substituents are as defined in the specification. Also disclosed are methods of preventing or minimising damage to plants comprising providing at least one thrips behaviour modifying compound of formula (I).
Patent NZ-553367-A (NZ)
Title: Trailer gate slide
Inventor: HUGO DARRYN
IPC: B60P7/06
Filed: 2005-07-21
Abstract: Disclosed is a trailer gate mobilisation device which includes a slide device adapted to run along an elongate mount on at least one side of a roof of a truck trailer. The slide device includes means to connect to an upper edge of a trailer gate.